Early Phase 1CompletedINTERVENTIONAL
GLP-1 and Hypoglycemia
ClinicalTrials.gov · NCT01858896 · Registry updated: 2026-11-06
- Condition / research focus
- Type 2 Diabetes Mellitus
- Sponsor
- University of Maryland, Baltimore
- Countries with listed sites
- United States
- Registry dates and results
- Start: 2013-07. Completion: 2026-02-26 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Glucagon-Like Peptide- 1 (GLP-1) infusion (drug) — also listed as: GLP-1
- Placebo Comparator: Saline Infusion (other) — also listed as: Saline infusion
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- University of Maryland, Baltimore
Baltimore, Maryland, United States
Site recruitment: Not reported